Euro-GASP external quality assessment (EQA) scheme for Neisseria gonorrhoeae antimicrobial susceptibility testing 2016
The EQA scheme is available to all laboratories in the STI surveillance network, which are mainly national reference laboratories or provide expert services (national or regional) in respect to N. gonorrhoeae diagnostics and antimicrobial susceptibility testing.
Strong engagement of national public health laboratories to respond to communicable disease outbreaks and improve monitoring of antimicrobial resistance in the European Union.
The EU Laboratory Capability (EULabCap) report published today,
on the results of the 2015 survey, concludes that the EU/EEA as a whole has a strong and improving public health microbiology system, with an average EULabCap score of 7.5 on a scale of 10, up from 6.9 in 2013 and 7.3 in 2014.
Laboratory surveillance of influenza
Surveillance of influenza virus infection at the European level requires close collaboration between virologists, epidemiologists and sentinel GP networks.
European Reference Laboratory Network for Human Influenza (ERLI-Net)
The ERLI-Net sub-network of reference laboratories of the European Influenza Surveillance Network carries out virological surveillance of human influenza in the EU/EEA through the EISN timely reporting mechanism and strengthening laboratory capacity for influenza virus detection, antiviral susceptibility testing and typing.
Target 3.1. Support to national surveillance networks
This score increased from intermediate to high from 2013 to 2014, when half of the EU/EEA countries showed high capacity/capability of their clinical/public health laboratories for reporting diagnostic information to surveillance databases.
Target 3.2. Active participation in EU/EEA disease networks
Target assessment suffered from business discontinuity in several ECDC-supported laboratory networks, resulting in one missing indicator in 2014 and two missing indicators in 2015.
Target 3.3. National outbreak response support
This NRL core function is a weaker target, with increasing scores over time as a group. In 2015, half of the EU/EEA countries had intermediate capacity/capability in preparedness and response to outbreaks, with a score of 7.0 or more.
Target 3.4. (Re)-emerging disease laboratory preparedness and response support
Over the years, the up-to-date diagnostic capability for rare and (re)emerging diseases improved in the EU/EEA, with half of the countries reaching a high level of capability in 2015